During the past decade, Les Centres GHESKIO Clinical Research Site (GHESKIO-INLR) CRS conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 7 clinical trials were completed, i.e. on average, 58.3% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 1 clinical trials were completed. i.e. 20% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Les Centres GHESKIO Clinical Research Site (GHESKIO-INLR) CRS" #1 collaborator was "National Institute of Allergy and Infectious Diseases (NIAID)" with 9 trials as a collaborator, "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 2 trials as a collaborator, "Gilead Sciences" with 2 trials as a collaborator, "AbbVie" with 1 trials as a collaborator and "Dimagi Inc." with 1 trials as a collaborator. Other collaborators include 5 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "Les Centres GHESKIO Clinical Research Site (GHESKIO-INLR) CRS" are "HIV Infections" (11 trials), "HIV Infection" (7 trials), "Tuberculosis" (7 trials), "HIV-1 Infection" (2 trials) and "Cardiovascular Diseases" (1 trials). Many other conditions were trialed in "Les Centres GHESKIO Clinical Research Site (GHESKIO-INLR) CRS" in a lesser frequency.

Most popular intervention types in "Les Centres GHESKIO Clinical Research Site (GHESKIO-INLR) CRS" are "Drug" (16 trials), "Dietary Supplement" (5 trials), "Biological" (3 trials), "Other" (3 trials) and "Behavioral" (2 trials). Other intervention types were less common.

The name of intervention was led by "Isoniazid (INH)" (6 trials), "Rifapentine (RPT)" (4 trials), "Pyridoxine (vitamin B6)" (3 trials), "Efavirenz" (2 trials) and "Emtricitabine" (2 trials). Other intervention names were less common.

The vast majority of trials in "Les Centres GHESKIO Clinical Research Site (GHESKIO-INLR) CRS" are 21 trials for "All" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "Les Centres GHESKIO Clinical Research Site (GHESKIO-INLR) CRS". undefined are not yet recruiting, 3 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 16 completed trials in Les Centres GHESKIO Clinical Research Site (GHESKIO-INLR) CRS, 2 suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Les Centres GHESKIO Clinical Research Site (GHESKIO-INLR) CRS, 3 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 3 trials that are defined as “Not Applicable".